Replimune Group, Inc. · NASDAQ:REPL
Xynos Konstantinos sold 16,198 Replimune Group, Inc. shares (Form 4)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Xynos Konstantinos (Chief Medical Officer) sold 16,198 Replimune Group, Inc. shares at US$21.60 for US$350K, leaving 208,017 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 16,198 shares
- Price
- US$21.60
- Value
- US$350K
- Holding after
- 208,017 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Common Stock | Sale | 16,198 | US$21.60 | 208,017 | Direct |
Source
Download original · View original at SEC
Related
- Replimune Group, Inc.
- Xynos Konstantinos
- Replimune Group, Inc. shareholders
- Form 4 · Xynos Konstantinos · Aug 12, 2026
- Form 4 · Xynos Konstantinos · May 20, 2026
- Form 4 · Xynos Konstantinos · Apr 7, 2026
- Form 4 · Schwendenman Andrew · Nov 18, 2026
- Form 4 · Patel Sushil · Nov 18, 2026
- Form 4 · Hill Emily Luisa · Nov 18, 2026
- Schedule 13G/A · Rtw Investments, LP · Nov 16, 2026
- Form 4 · Slattery Joseph P · Nov 10, 2026